Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib.


Olmez O. F., Bilici A., Gursoy P., Cubukcu E., Sakin A., Korkmaz T., ...More

Pulmonology, 2022 (Peer-Reviewed Journal) identifier